FLI1 and systemic sclerosis: We currently focused on the contribution of Fli1 haploinsufficiency to dermal fibroblast-dependent transdifferentiation of Tregs during the inflammatory phase of an SSc-like condition; therefore, we can say that BLM-treated mice would be suitable for addressing this issue.